Mitral TEER for Primary MR in the very elderly, presented by M. J. Price
MitraClip™ TEER is safe and effective across all age groups, including the very elderly. Next-generation devices provide consistent benefits in MR reduction, LV remodeling, and quality of life, regardless of age.
LEARN MORE:
Related Resources
bRIGHT 2-year real-world outcomes
Prognosis of TR after MitraClip for MR
TRILUMINATE Pivotal - 2-year update EuroPCR 25
EXPAND Study: Data overview
Data Summary PFO closure in patients > 60 Years
PCR LV 2021: Navitor™ 30-day outcomes
bRIGHT study
ESOC presentation: PFO closure in patients > 60 Years
EuroPCR 2022: TAVI 1yr outcomes
TRENDING TOPICS
TEER G5 Brochure 2025
TRILUMINATE Pivotal - 2-year update EuroPCR 25
Prognosis of TR after MitraClip for MR
